224 related articles for article (PubMed ID: 21255435)
61. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
62. LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation.
Cheng D; Deng J; Zhang B; He X; Meng Z; Li G; Ye H; Zheng S; Wei L; Deng X; Chen R; Zhou J
EBioMedicine; 2018 Oct; 36():159-170. PubMed ID: 30195653
[TBL] [Abstract][Full Text] [Related]
63. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases.
Chen KC; Wang YS; Hu CY; Chang WC; Liao YC; Dai CY; Juo SH
FASEB J; 2011 May; 25(5):1718-28. PubMed ID: 21266537
[TBL] [Abstract][Full Text] [Related]
64. MicroRNAs in cancer diagnosis and therapy: from bench to bedside.
Hoshino I; Matsubara H
Surg Today; 2013 May; 43(5):467-78. PubMed ID: 23129027
[TBL] [Abstract][Full Text] [Related]
65. Investigating the epi-miRNome: identification of epi-miRNAs using transfection experiments.
Reale E; Taverna D; Cantini L; Martignetti L; Osella M; De Pittà C; Virga F; Orso F; Caselle M
Epigenomics; 2019 Nov; 11(14):1581-1599. PubMed ID: 31693439
[No Abstract] [Full Text] [Related]
66. Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer.
Watanabe K; Emoto N; Hamano E; Sunohara M; Kawakami M; Kage H; Kitano K; Nakajima J; Goto A; Fukayama M; Nagase T; Yatomi Y; Ohishi N; Takai D
Int J Cancer; 2012 Jun; 130(11):2580-90. PubMed ID: 21702040
[TBL] [Abstract][Full Text] [Related]
67. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.
Xiao Y; Su M; Ou W; Wang H; Tian B; Ma J; Tang J; Wu J; Wu Z; Wang W; Zhou Y
Biomed Pharmacother; 2019 Sep; 117():109192. PubMed ID: 31387188
[TBL] [Abstract][Full Text] [Related]
68. Analyses in human urothelial cells identify methylation of miR-152, miR-200b and miR-10a genes as candidate bladder cancer biomarkers.
Köhler CU; Bryk O; Meier S; Lang K; Rozynek P; Brüning T; Käfferlein HU
Biochem Biophys Res Commun; 2013 Aug; 438(1):48-53. PubMed ID: 23867826
[TBL] [Abstract][Full Text] [Related]
69. MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme.
Ghasemi A; Fallah S; Ansari M
Biochem Cell Biol; 2016 Dec; 94(6):569-576. PubMed ID: 27783537
[TBL] [Abstract][Full Text] [Related]
70. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect.
Suzuki H; Yamamoto E; Nojima M; Kai M; Yamano HO; Yoshikawa K; Kimura T; Kudo T; Harada E; Sugai T; Takamaru H; Niinuma T; Maruyama R; Yamamoto H; Tokino T; Imai K; Toyota M; Shinomura Y
Carcinogenesis; 2010 Dec; 31(12):2066-73. PubMed ID: 20924086
[TBL] [Abstract][Full Text] [Related]
71. MicroRNA-31 Function as a Suppressor Was Regulated by Epigenetic Mechanisms in Gastric Cancer.
Wei J; Wang Z; Wang Z; Yang Y; Fu C; Zhu J; Jiang D
Biomed Res Int; 2017; 2017():5348490. PubMed ID: 29333444
[TBL] [Abstract][Full Text] [Related]
72. MicroRNAs: Diverse Mechanisms of Action and Their Potential Applications as Cancer Epi-Therapeutics.
Sadakierska-Chudy A
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32906681
[TBL] [Abstract][Full Text] [Related]
73. The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation.
Gasque Schoof CR; Izzotti A; Jasiulionis MG; Vasques Ldos R
Biomed Res Int; 2015; 2015():634749. PubMed ID: 26618174
[TBL] [Abstract][Full Text] [Related]
74. Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer.
Yi JM; Kang EJ; Kwon HM; Bae JH; Kang K; Ahuja N; Yang K
Oncotarget; 2017 Apr; 8(16):26600-26612. PubMed ID: 28460450
[TBL] [Abstract][Full Text] [Related]
75. MiRNAs, epigenetics, and cancer.
Rouhi A; Mager DL; Humphries RK; Kuchenbauer F
Mamm Genome; 2008 Aug; 19(7-8):517-25. PubMed ID: 18688563
[TBL] [Abstract][Full Text] [Related]
76. Epigenetic Alternations of MicroRNAs and DNA Methylation Contribute to Liver Metastasis of Colorectal Cancer.
Liu J; Li H; Sun L; Shen S; Zhou Q; Yuan Y; Xing C
Dig Dis Sci; 2019 Jun; 64(6):1523-1534. PubMed ID: 30604369
[TBL] [Abstract][Full Text] [Related]
77. Bioinformatics analysis of the interactions among lncRNA, miRNA and mRNA expression, genetic mutations and epigenetic modifications in hepatocellular carcinoma.
Lin C; Yuan G; Hu Z; Zeng Y; Qiu X; Yu H; He S
Mol Med Rep; 2019 Feb; 19(2):1356-1364. PubMed ID: 30535497
[TBL] [Abstract][Full Text] [Related]
78. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
79. VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription.
Singh PK; Long MD; Battaglia S; Hu Q; Liu S; Sucheston-Campbell LE; Campbell MJ
Epigenetics; 2015; 10(1):40-9. PubMed ID: 25494645
[TBL] [Abstract][Full Text] [Related]
80. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
